Home » Paladin Expands Distribution Agreement With Shire HGT to Include Elaprase (Idursulfase)
Paladin Expands Distribution Agreement With Shire HGT to Include Elaprase (Idursulfase)
Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, announced that it has expanded its current exclusive Canadian distribution agreement with Shire Human Genetic Therapies, Inc.
Marketwire
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May